Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug, suzetrigine, ...
Scientists are developing a "sponge" that can soak up pain signals in the body before they reach the brain, potentially ...
Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...
The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals before ...
UNIVERSITY PARK, Pa. — Many people suffering from the constant nagging of back pain often wind up turning to painkillers to bring relief to their frustrating ailment. But new research suggests there ...
A new study finds that an increasing number of surgeries — and the painkillers that follow — could derail recovery for those who once misused opioids.
Please provide your email address to receive an email when new articles are posted on . Opioids prescribing declined from 2016 to 2020 for patients with cancer in Connecticut who did not report ...
The University of Cincinnati is testing non-opioid treatments for headaches after strokes in a clinical trial.
Please provide your email address to receive an email when new articles are posted on . Three measures of opioid prescribing for people with cancer declined significantly after cannabis dispensaries ...
This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. It's a question spine surgeon Richard ...
Add Yahoo as a preferred source to see more of our stories on Google. For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to ...